谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Immunogenicity and safety of AZD1222 (ChAdOx1 nCoV-19) against SARS-CoV-2 in Japan: a double-blind, randomized controlled phase 1/2 trial

Michiko Asano, Hiroshi Okada,Yohji Itoh,Hajime Hirata,Kensuke Ishikawa,Erika Yoshida,Akiko Matsui,Elizabeth J Kelly,Kathryn Shoemaker,Urban Olsson,Johan Vekemans

International Journal of Infectious Diseases（2022）

引用 16|浏览25
暂无评分
关键词
COVID-19,ChAdOx1 nCoV-19,AZD1222,Japan,Elderly adult,Humoral response
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要